Nancy L Noble

age ~61

from Clearfield, UT

Get Report

Also known as:

Nancy Lynne Williams
Nancy L Williams
Nancy Lynne Surface
Nancy L Surface
Nicholas C Bailey

Connected to:

Nancy Noble Phones & Addresses

Clearfield, UT
Spring, TX
955 W Willow Garden Paseo, Farmington, UT 84025
Indianapolis, IN
Fishers, IN
Buena Vista, CO
Avon, IN
Colorado Springs, CO
Flagstaff, AZ

Specialities

Litigation

Resumes

Nancy Noble Ithaca, NY

view source

Work:

1st Garden Maintenance
Portsmouth
Dec 2009 to Sep 2012
Office Assistant/Receptionist England 1st Caravan Hire Ltd

2006 to 2009
Owner/Director/Partner England- Sharps Bedrooms

2005 to 2007
Sales consultant Realty USA
Ithaca, NY
2002 to 2004
Real Estate Agent Texas Outdoor design Center LLC
Houston, TX
2000 to 2002
Owner /Director Leisure Collections
Houston, TX
1989 to 2000
Chair King The Chair King
Austin, TX
1984 to 1989
manager of the Chair King relocated The Chair King
Houston, TX
1980 to 1984
Positions heldabove at all Chair King locations and leisure Collections- supervisory

Education:

ALLEN SCHOOL of Health Science
Brooklyn, NY
2012 to 2013
certificate of completion upon graduation in June 2013--- 4.0 GPA in Medical Billing and Coding

Nancy Noble Fishers, IN

view source

Work:

SIMON PROPERTY GROUP

2008 to 2000
Paralegal SIMON PROPERTY GROUP

2007 to 2008
Legal Assistant LEE AND RYAN ENVIRONMENTAL CONSULTING, INC

2006 to 2007
Federal Contracting Project Coordinator KELLY SERVICES

2006 to 2006
Project Assistant OMNI MANAGEMENT SERVICES, INC

2006 to 2006
Residential Property Manager PULTE HOMES

2002 to 2006
Land Development Coordinator CLASSIC GENERAL CONTRACTORS

2000 to 2002
Project Coordinator

Education:

BROWN MACKIE COLLEGE
Indianapolis, IN
2010 to 2012
Associates Degree in Paralegal Studies Remington College
Colorado Springs, CO
2000 to 2002
Associates Degree in Computer Information Systems

Skills:

Transactional Paralegal, Legal Research, Commercial Loan Closings, Contract Documents, Corporate Documents, Organizational Skills, Budget Maintenance

Lawyers & Attorneys

Nancy Noble - Lawyer

view source

Specialties:

Litigation

ISLN:

900941618

Admitted:

1991

License Records

Nancy Lynn Noble

License #:

28339 - Active

Category:

Cosmetology

Issued Date:

Sep 1, 1976

Effective Date:

Sep 1, 1976

Expiration Date:

Dec 31, 2018

Type:

Cosmetologist

Nancy Maud Noble

License #:

58786 - Expired

Category:

Nursing

Issued Date:

Jul 2, 2001

Effective Date:

Jan 3, 2003

Expiration Date:

Oct 31, 2002

Type:

Registered Nurse

Name / Title

Company / Classification

Phones & Addresses

Nancy Noble

PacCoin
Pacific Coin Centre Ltd.
Numismatics

PO Box 28178, 2945 Jacklin Rd, Victoria, BC V9B 5E3
2504784418

Nancy S Noble

SUMMER PLACE, LTD

Nancy Noble

NANCY'S ENTERPRISE LLC

Nancy Noble

PacCoin
Numismatics

2504784418

Nancy D. Noble
Director, Vice President

Coggin Automotive Corp
Ret New/Used Automobiles

9049924110

Us Patents

Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
view source
US Patent:

6906026, Jun 14, 2005
Filed:

Jul 5, 2000
Appl. No.:

09/869820
Inventors:

Nancy A. Noble - Salt Lake City UT, US
Wayne A. Border - Salt Lake City UT, US
Assignee:

The University of Research Foundation - Salt Lake City UT
International Classification:

A61K048/00
A61K039/395
A61K038/00
US Classification:

514 2, 514 4, 514 44, 435 4, 435 6, 435 71
Abstract:

The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGFβ, or using agents that inhibit TGFβ in combination with agents that degrade excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.

Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
view source
US Patent:

7713924, May 11, 2010
Filed:

Jul 8, 2004
Appl. No.:

10/887378
Inventors:

Nancy A. Noble - Salt Lake City UT, US
Wayne A. Border - Salt Lake City UT, US
Daniel A. Lawrence - Derwood MD, US
Assignee:

University of Utah Research Foundation - Salt Lake City UT
The American National Red Cross - Rockville MD
International Classification:

A61K 38/14
A61K 38/55
A61K 31/401
C12Q 1/68
US Classification:

514 2, 514 4, 514 44, 435 4, 435 6, 435 71
Abstract:

The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGFβ, or using agents that inhibit TGFβ in combination with agents that degrade excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.

Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
view source
US Patent:

7763580, Jul 27, 2010
Filed:

Sep 27, 2004
Appl. No.:

10/952361
Inventors:

Nancy A. Noble - Salt Lake City UT, US
Wayne A. Border - Salt Lake City UT, US
Assignee:

University of Utah Research Foundation - Salt Lake City UT
International Classification:

A61K 38/14
A61K 38/55
A61K 31/4164
A61K 31/401
C12Q 1/68
US Classification:

514 2, 514 4, 514 44 A, 435 6, 435375, 435 4, 435 71
Abstract:

The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGFβ, or using agents that inhibit TGFβ in combination with agents that degrade excess accumulated extracellular matrix, or at least one agent that degrades excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.

Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
view source
US Patent:

20080175848, Jul 24, 2008
Filed:

Oct 30, 2007
Appl. No.:

11/981283
Inventors:

Nancy A. Noble - Salt Lake City UT, US
Wayne A. Border - Salt Lake City UT, US
Assignee:

University of Utah Research Foundation - Salt Lake City UT
International Classification:

A61K 48/00
A61K 31/473
A61K 31/403
A61K 31/401
A61K 39/395
US Classification:

4241461, 514412, 514423, 514 44, 514290
Abstract:

The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGFβ, or using agents that inhibit TGFβ in combination with agents that degrade excess accumulated extracellular matrix, or at least one agent that degrades excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.

Methods For Preventing And Treating Fibrotic Diseases Resulting From Accumulation Of Excess Extracellular Matrix Induced By Tgf.beta. Using Renin Inhibitors
view source
US Patent:

6316258, Nov 13, 2001
Filed:

Dec 15, 1998
Appl. No.:

9/211916
Inventors:

Nancy A. Noble - Salt Lake City UT
Wayne A. Border - Salt Lake City UT
Assignee:

University of Utah - Salt Lake City UT
International Classification:

G01N 3350
US Classification:

435375
Abstract:

The present invention is methods for inhibiting the renin-induced production of TGF. beta. using a renin inhibitory agent to reduce excess accumulation of extracellular matrix in tissue in a subject, and to the use of renin inhibitory agents and additional TGF. beta. inhibitory agents to reduce TGF. beta. production to treat and prevent fibrotic diseases.